Project Grant R01EB038005
Award Date
8/1/25
Completion Date
4/30/29
Dollars Obligated
$651K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, will provide $408,750 from January 1, 2025 to November 30, 2029 to Trustees of Boston University to develop synthetic oligonucleotide nanostructures that can molecularly program interfacial interactions at immune interfaces. The goal is to uncover the impact of molecular cargo packaging on immunomodulation, focusing on how cargo...
This $447,747 Project Grant award from the National Science Foundation (NSF) Engineering Program (CFDA 47.041) to Trustees of Boston University will develop a novel plasmonic nanosensor system to detect two important classes of RNA molecules - microRNA (miRNA) biomarkers and SARS-CoV-2 viral RNA. The sensor platform uses DNA structures with nanoparticle probes that undergo conformational changes when binding to target RNAs, altering the plasmonic coupling signal which is detected via two-color...
This $3,000,000 project grant, awarded by the National Science Foundation (NSF) under the Engineering (CFDA 47.041) program, aims to solve the long-standing challenge of developing self-amplifying ribonucleic acid (SARNA) technologies. The project, led by Trustees of Boston University, a private non-profit research university, will: Synthesize a diverse library of modified nucleoside triphosphates (ModNTPs) and use them to produce modified SARNA with extended cellular half-life. Evaluate the...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $1,158,262 Project Grant (CFDA 93.286) to the University of Massachusetts Medical School to develop a synthetic RNA switch technology that can precisely control the timing and dosage of gene therapies delivered via adeno-associated viral (AAV) vectors. The project aims to optimize a highly efficient, leak-free RNA switch system to regulate transgene expression for therapeutic applications, including dose control of...
This $3.7 million project grant from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering will fund research at Arizona State University to develop RNA stabilizing elements that improve coronavirus diagnostics. Specifically, the university will model the role of 5' secondary structures in modulating mRNA stability, optimize sensing RNAs to detect SARS-CoV-2, and use degradable trans-acting RNAs to enhance sample and amplified RNA stability....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), provides $489,500 to support structural studies of the full-length nucleocapsid (N) protein of SARS-CoV-2. The goal is to determine the high-resolution structure of the full-length N protein in complex with the viral RNA using cryogenic electron microscopy. This research aims to advance the understanding of the...
This $122,577 Project Grant awarded by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) supports research to develop and characterize self-amplifying RNA lipid nanoparticles for gene delivery to solid tumors. The primary aims are to: 1) Screen and optimize the self-amplifying RNA and lipid nanoparticle formulation for efficient gene delivery across multiple tumor types, using a gene drive cassette to selectively express a suicide gene in tumors; and 2) Maximize the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $303,024 to Biocognon LLC to develop an innovative combinatorial pipeline for discovering nanobody-based therapeutics targeting G-protein coupled receptors (GPCRs). The key products and services to be delivered under this award include: (1) developing a robust assembly system for GPCR and nanobody libraries, (2) building a...
This $821,426 Project Grant, awarded on January 16, 2025 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286 - Discovery and Applied Research for Technological Innovations to Improve Human Health, is funding research to develop nanostructures that selectively target bacteria and create computational models to predict their activity and behavior. The key objectives are to: Use computer-guided design to create and test antimicrobial nanostructures against...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), aims to measure and understand the molecular mechanisms of viral nucleocapsid self-assembly and disassembly. The $370,190 award, effective May 10, 2025 through March 31, 2030, will use a combination of quantitative experimental methods, including interferometric scattering microscopy and cryo-electron microscopy, to study...